Can Fite Bio Pharma Ltd. - Understand $canf stock

$CANF Market Cap: $53.04 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$743.0K

TTM

Gross Margin

Net Earnings

-$7.634M

TTM

Current Assets

$9.908M

Q4 2023

Current Liabilities

$2.020M

Q4 2023

Current Ratio

490.5%

Q4 2023

Total Assets

$9.989M

Q4 2023

Total Liabilities

$3.746M

Q4 2023

Book Value

$6.243M

Q4 2023

Cash

$4.278M

Q4 2023

P/E

-6.948

Nov 29, 2024 EST

Free Cash Flow

-$8.442M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003
Revenue	$743.0K	$810.0K	$853.0K	$763.0K	$2.032M	$3.820M	$789.0K	$165.0K	$196.9K	$0.00	$0.00	$0.00	$500.0K	$710.0K	$840.0K	$1.530M	$510.0K	$2.900M	$0.00	$0.00	$0.00
YoY Change	-8.27%	-5.04%	11.8%	-62.45%	-46.81%	384.16%	378.18%	-16.19%				-100.0%	-29.58%	-15.48%	-45.1%	200.0%	-82.41%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003
Revenue	$743.0K	$810.0K	$853.0K	$763.0K	$2.032M	$3.820M	$789.0K	$165.0K	$196.9K	$0.00	$0.00	$0.00	$500.0K	$710.0K	$840.0K	$1.530M	$510.0K	$2.900M	$0.00	$0.00	$0.00
Cost Of Revenue							$74.00K	$49.00K	$131.7K	$199.0K	$200.0K	$100.0K
Gross Profit							$715.0K	$116.0K	$65.21K	-$199.0K	-$200.0K	-$100.0K
Gross Profit Margin							90.62%	70.3%	33.13%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003
Selling, General & Admin	$2.955M	$263.0K	$9.848M	$11.95M	$10.97M	$6.082M	$2.903M	$2.767M	$3.298M	$3.263M	$4.460M	$2.450M	$1.960M	$1.590M	$1.510M	$2.040M	$1.900M	$2.100M	$1.200M	$1.200M	$940.0K
YoY Change	1023.57%	-97.33%	-17.59%	8.93%	80.37%	109.51%	4.92%	-16.09%	1.07%	-26.85%	82.04%	25.0%	23.27%	5.3%	-25.98%	7.37%	-9.52%	75.0%	0.0%	27.66%	34.29%
% of Gross Profit							406.01%	2385.34%	5056.37%
Research & Development	$5.983M	$7.763M	$3.847M	$2.952M	$3.069M	$3.152M	$4.978M	$6.014M	$4.415M	$4.256M	$4.020M	$3.250M	$3.630M	$2.680M	$3.530M	$7.160M	$8.560M	$7.680M	$1.620M	$2.660M	$3.810M
YoY Change	-22.93%	101.79%	30.32%	-3.81%	-2.63%	-36.68%	-17.23%	36.21%	3.74%	5.88%	23.69%	-10.47%	35.45%	-24.08%	-50.7%	-16.36%	11.46%	374.07%	-39.1%	-30.18%	-13.8%
% of Gross Profit							696.22%	5184.48%	6770.46%
Depreciation & Amortization	$15.00K	$14.00K	$14.00K	$12.00K	$14.00K	$14.00K	$19.00K	$18.00K	$19.60K	$13.08K	$20.00K	$20.00K	$60.00K	$70.00K	$100.0K	$110.0K	$90.00K	$120.0K	$130.0K	$140.0K	$130.0K
YoY Change	7.14%	0.0%	16.67%	-14.29%	0.0%	-26.32%	5.56%	-8.14%	49.79%	-34.59%	0.0%	-66.67%	-14.29%	-30.0%	-9.09%	22.22%	-25.0%	-7.69%	-7.14%	7.69%	116.67%
% of Gross Profit							2.66%	15.52%	30.05%
Operating Expenses	$5.983M	$8.026M	$13.70M	$14.90M	$14.04M	$9.234M	$7.900M	$8.799M	$7.732M	$7.531M	$8.490M	$5.720M	$5.590M	$4.290M	$5.060M	$9.200M	$10.45M	$9.790M	$2.820M	$3.860M	$4.750M
YoY Change	-25.45%	-41.39%	-8.1%	6.15%	52.04%	16.89%	-10.22%	13.79%	2.67%	-11.29%	48.43%	2.33%	30.3%	-15.22%	-45.0%	-11.96%	6.74%	247.16%	-26.94%	-18.74%	-7.23%
Operating Profit	-$8.195M	-$10.10M	-$12.84M	-$14.14M			-$7.185M	-$8.683M	-$7.667M	-$7.730M	-$8.690M	-$5.820M
YoY Change	-18.83%	-21.38%	-9.17%				-17.25%	13.25%	-0.81%	-11.05%	49.31%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003
Interest Expense	$575.0K	-$61.00K	$245.0K	$82.00K	-$170.0K	-$708.0K	$40.00K	$358.0K	$2.294M	$1.253M	$160.0K	$140.0K	$470.0K	$240.0K	$220.0K	$400.0K	$0.00	-$120.0K	-$280.0K	$70.00K
YoY Change	-1042.62%	-124.9%	198.78%	-148.24%	-75.99%	-1870.0%	-88.83%	-84.39%	83.14%	682.82%	14.29%	-70.21%	95.83%	9.09%	-45.0%		-100.0%	-57.14%	-500.0%
% of Operating Profit
Other Income/Expense, Net	$561.0K	-$77.00K	-$18.00K	-$386.0K	-$448.0K	-$445.0K	-$28.00K	-$39.00K	-$674.5K	-$341.8K	-$20.00K	-$10.00K	-$3.280M	-$100.0K	-$10.00K	-$10.00K					-$200.0K
YoY Change	-828.57%	327.78%	-95.34%	-13.84%	0.67%	1489.29%	-28.21%	-94.22%	97.34%	1608.98%	100.0%	-99.7%	3180.0%	900.0%	0.0%						-2100.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003
Pretax Income	-$7.634M	-$10.17M	-$12.62M	-$14.44M	-$12.63M	-$6.567M	-$6.404M	-$8.364M	-$6.048M	-$6.819M	-$8.550M	-$5.680M	-$7.900M	-$3.430M	-$4.010M	-$7.280M	-$9.950M	-$7.010M	-$3.090M	-$3.790M	-$4.960M
YoY Change	-24.96%	-19.36%	-12.66%	14.4%	92.25%	2.55%	-23.43%	38.3%	-11.31%	-20.24%	50.53%	-28.1%	130.32%	-14.46%	-44.92%	-26.83%	41.94%	126.86%	-18.47%	-23.59%	-2.94%
Income Tax	$0.00	$0.00	$0.00	$0.00	$0.00	$4.000K	$29.00K	$29.00K	$5.205K	$6.402K	$0.00	$0.00	$50.00K	$60.00K	$70.00K	$150.0K	$50.00K	$290.0K	$0.00
% Of Pretax Income
Net Earnings	-$7.634M	-$10.17M	-$12.62M	-$14.44M	-$12.63M	-$6.571M	-$6.339M	-$8.257M	-$5.733M	-$6.613M	-$8.060M	-$5.410M	-$7.140M	-$3.500M	-$4.080M	-$7.430M	-$10.00M	-$7.300M	-$3.090M	-$3.790M	-$4.960M
YoY Change	-24.96%	-19.36%	-12.66%	14.4%	92.13%	3.66%	-23.23%	44.01%	-13.3%	-17.95%	48.98%	-24.23%	104.0%	-14.22%	-45.09%	-25.7%	36.99%	136.25%	-18.47%	-23.59%	-2.94%
Net Earnings / Revenue	-1027.46%	-1255.93%	-1478.9%	-1892.92%	-621.31%	-172.02%	-803.42%	-5004.24%	-2912.28%				-1428.0%	-492.96%	-485.71%	-485.62%	-1960.78%	-251.72%
Basic Earnings Per Share	-$0.01	-$0.01	-$0.03	-$0.04
Diluted Earnings Per Share	-$0.01	-$0.01	-$22.81K	-$40.30K	-$147.0K	-$168.9K	-$190.0K	-$300.0K	-$249.8K	-$376.9K	-$587.9K	-$541.0K	-$685.2K	-$402.8K	-$510.6K	-$977.6K	-$1.340M	-$1.318M	-$600.0K	-$735.9K	-$963.1K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003
Cash & Short-Term Investments	$4.297M	$2.986M	$4.627M	$8.343M	$2.761M	$3.888M	$3.505M	$9.029M	$20.22M	$10.05M	$5.990M	$1.150M	$3.840M	$4.970M	$5.020M	$5.290M	$11.87M	$8.800M	$7.550M	$660.0K	$1.940M
YoY Change	43.9%	-35.47%	-44.54%	202.17%	-28.99%	10.93%	-61.18%	-55.34%	101.24%	67.7%	420.87%	-70.05%	-22.74%	-1.0%	-5.1%	-55.43%	34.89%	16.56%	1043.94%	-65.98%
Cash & Equivalents	$4.278M	$2.978M	$4.390M	$8.268M	$2.697M	$3.615M	$3.505M	$9.029M	$20.22M	$10.05M	$5.990M				$5.020M	$5.290M	$11.87M	$2.140M	$7.550M	$660.0K	$1.940M
Short-Term Investments	$19.00K	$8.000K	$237.0K	$75.00K	$64.00K	$273.0K	$0.00			$0.00		$150.0K	$3.720M	$4.720M				$6.670M
Other Short-Term Assets	$5.533M	$6.124M	$15.39M	$1.039M	$3.732M	$3.974M	$3.093M	$2.193M	$666.5K	$875.4K	$570.0K	$420.0K	$890.0K	$120.0K
YoY Change	-9.65%	-60.22%	1381.52%	-72.16%	-6.09%	28.48%	41.02%	229.05%	-23.86%	53.57%	35.71%	-52.81%	641.67%
Inventory
Prepaid Expenses
Receivables						$41.00K	$66.00K	$24.31K	$74.09K	$75.71K	$60.00K	$30.00K	$100.0K	$40.00K	$120.0K	$230.0K	$500.0K	$730.0K	$140.0K	$50.00K	$120.0K
Other Receivables						$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.908M	$9.157M	$20.07M	$9.400M	$7.144M	$7.903M	$6.664M	$11.25M	$20.96M	$11.00M	$6.610M	$1.600M	$4.830M	$5.130M	$5.140M	$5.520M	$12.37M	$9.530M	$7.690M	$710.0K	$2.060M
YoY Change	8.2%	-54.37%	113.49%	31.58%	-9.6%	18.59%	-40.74%	-46.33%	90.57%	66.36%	313.13%	-66.87%	-5.85%	-0.19%	-6.88%	-55.38%	29.8%	23.93%	983.1%	-65.53%
Property, Plant & Equipment	$81.00K	$126.0K	$185.0K	$123.0K	$118.0K	$47.00K	$28.00K	$59.32K	$72.26K	$37.02K	$40.00K	$40.00K	$70.00K	$140.0K	$170.0K	$270.0K	$330.0K	$380.0K	$370.0K	$520.0K	$650.0K
YoY Change	-35.71%	-31.89%	50.41%	4.24%	151.06%	67.86%	-52.8%	-17.91%	95.19%	-7.46%	0.0%	-42.86%	-50.0%	-17.65%	-37.04%	-18.18%	-13.16%	2.7%	-28.85%	-20.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments						$0.00	$917.0K			$0.00
YoY Change						-100.0%
Other Assets
YoY Change
Total Long-Term Assets	$81.00K	$126.0K	$185.0K	$123.0K	$1.030M	$49.00K	$950.0K	$70.02K	$80.52K	$44.26K	$60.00K	$40.00K	$70.00K	$140.0K	$170.0K	$270.0K	$330.0K	$380.0K	$370.0K	$520.0K	$650.0K
YoY Change	-35.71%	-31.89%	50.41%	-88.06%	2002.04%	-94.84%	1256.68%	-13.04%	81.95%	-26.24%	50.0%	-42.86%	-50.0%	-17.65%	-37.04%	-18.18%	-13.16%	2.7%	-28.85%	-20.0%
Total Assets	$9.989M	$9.283M	$20.25M	$9.523M	$8.174M	$7.952M	$7.614M	$11.32M	$21.04M	$11.04M	$6.670M	$1.640M	$4.900M	$5.270M	$5.310M	$5.790M	$12.70M	$9.910M	$8.060M	$1.230M	$2.710M
YoY Change
Accounts Payable	$427.0K	$896.0K	$954.0K	$561.0K	$2.156M	$1.071M	$427.0K	$1.390M	$552.0K	$276.9K	$510.0K	$760.0K	$510.0K	$150.0K	$170.0K	$690.0K	$690.0K	$510.0K	$50.00K	$180.0K	$320.0K
YoY Change	-52.34%	-6.08%	70.05%	-73.98%	101.31%	150.82%	-69.28%	151.8%	99.33%	-45.7%	-32.89%	49.02%	240.0%	-11.76%	-75.36%	0.0%	35.29%	920.0%	-72.22%	-43.75%
Accrued Expenses	$971.0K	$823.0K	$958.0K	$374.0K	$36.00K	$1.122M	$997.0K	$1.038M	$1.310M	$1.322M	$1.520M	$1.230M	$550.0K	$330.0K
YoY Change	17.98%	-14.09%	156.15%	938.89%	-96.79%	12.54%	-3.97%	-20.76%	-0.9%	-13.02%	23.58%	123.64%	66.67%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$2.640M	$0.00
YoY Change																			-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.020M	$2.502M	$2.730M	$1.269M	$3.271M	$3.119M	$1.754M	$2.786M	$2.125M	$1.607M	$2.150M	$2.330M	$1.350M	$1.120M	$1.250M	$1.860M	$2.290M	$790.0K	$260.0K	$3.070M	$650.0K
YoY Change	-19.26%	-8.35%	115.13%	-61.2%	4.87%	77.82%	-37.05%	31.14%	32.2%	-25.25%	-7.73%	72.59%	20.54%	-10.4%	-32.8%	-18.78%	189.87%	203.85%	-91.53%	372.31%
Long-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.726M	$2.309M	$3.141M	$2.180M	$2.461M	$1.818M	$846.0K	$4.218M	$6.428M	$2.002M	$40.00K	$20.00K	$260.0K	$430.0K	$500.0K	$10.00K	$10.00K	$20.00K	$20.00K	$20.00K	$20.00K
YoY Change	-25.25%	-26.49%	44.08%	-11.42%	35.37%	114.89%	-79.94%	-34.38%	221.09%	4905.15%	100.0%	-92.31%	-39.53%	-14.0%	4900.0%	0.0%	-50.0%	0.0%	0.0%	0.0%
Total Long-Term Liabilities	$1.726M	$2.309M	$3.141M	$2.180M	$2.461M	$1.818M	$846.0K	$4.218M	$6.428M	$2.002M	$40.00K	$20.00K	$260.0K	$430.0K	$500.0K	$10.00K	$10.00K	$20.00K	$20.00K	$20.00K	$20.00K
YoY Change	-25.25%	-26.49%	44.08%	-11.42%	35.37%	114.89%	-79.94%	-34.38%	221.09%	4905.15%	100.0%	-92.31%	-39.53%	-14.0%	4900.0%	0.0%	-50.0%	0.0%	0.0%	0.0%
Total Liabilities	$3.746M	$4.811M	$5.871M	$3.449M	$5.732M	$4.937M	$2.600M	$7.014M	$8.707M	$4.016M	$2.850M	$2.890M	$2.190M	$1.550M	$1.750M	$1.870M	$2.290M	$810.0K	$270.0K	$3.080M	$670.0K
YoY Change	-22.14%	-18.05%	70.22%	-39.83%	16.1%	89.88%	-62.93%	-19.45%	116.84%	40.9%	-1.38%	31.96%	41.29%	-11.43%	-6.42%	-18.34%	182.72%	200.0%	-91.23%	359.7%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020
Basic Shares Outstanding	1.278B shares	815.7M shares	553.1M shares	358.4M shares
Diluted Shares Outstanding	1.278B shares	815.7M shares	553.1M shares	358.4M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $53.039 Million

About Can-Fite BioPharma Ltd.

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The firm co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

Industry: Pharmaceutical Preparations Peers: Enlivex Therapeutics Ltd. CollPlant Biotechnologies Ltd Protalix BioTherapeutics, Inc. Gamida Cell Ltd. KAMADA LTD UroGen Pharma Ltd.